ARCH VENTURE FUND IX, L.P. - BOUNDLESS BIO -- SCH 13D

Company

Boundless Bio, Inc.

Filed

October 29, 2024

Accession Number

0001072613-24-000789

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →